×

Premium Content - Please Submit to Continue:

First Name
Last Name
Company
Thank you!
Error - something went wrong!

A Review of Patient Reported Outcome Labels in the U.S. - 2006-2013

March 24, 2015

Recorded Live May 15, 2014

Analysis of PRO Evidence for Orphan Drug Label Claims

In this webinar, we go over background information on orphan drugs, priority and standard reviews,  PROs in rare diseases. Then, we analyze the results from reviewing product labels and drug approval packages (DAPs) for orphan drugs from January 2006. Our guest speaker is Ari Gnanasakthy.

Previous
Integrating Today's eCOA Solutions Intelligently and Efficiently
Integrating Today's eCOA Solutions Intelligently and Efficiently

<p>Recorded Live March 27,2014</p>

Next
Overcoming Logistical Challenges in Global Clinical Trials
Overcoming Logistical Challenges in Global Clinical Trials

<p>Recorded Live June 12, 2014</p>